Jingmei Luo

ORCID: 0000-0001-9389-1110
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipid metabolism and disorders
  • Circular RNAs in diseases
  • MicroRNA in disease regulation
  • Chronic Kidney Disease and Diabetes
  • Pancreatic function and diabetes
  • Kruppel-like factors research
  • Apelin-related biomedical research
  • Diabetes Treatment and Management
  • Cancer-related molecular mechanisms research
  • Neuroendocrine Tumor Research Advances
  • Diabetes Management and Research
  • Ferroptosis and cancer prognosis
  • Cancer Immunotherapy and Biomarkers
  • Diabetes and associated disorders

First Affiliated Hospital of Kunming Medical University
2022-2024

Kunming Medical University
2022-2023

There are no reliable molecular targets for early diagnosis and effective treatment in the clinical management of diabetic kidney disease (DKD). To identify novel gene factors underlying progression DKD.The public transcriptomic datasets alloxan-induced DKD model streptozotocin-induced were retrieved to perform an integrative bioinformatic analysis differentially expressed genes (DEGs) shared by two experimental animal models. The dominant biological processes pathways associated with DEGs...

10.1186/s12882-023-03362-4 article EN cc-by BMC Nephrology 2023-10-18

The immune-related adverse events associated with immunotherapy may affect endocrine glands and other tissues. Two Chinese patients malignancies were treated programmed cell death-1 (PD-1) inhibitors (nivolumab pembrolizumab) followed up biochemical tests over 1 year. After PD-1 treatment for 6 to 10 months, the developed symptoms of diabetes, ketoacidosis, insulin secretion failure. Type diabetes mellitus was confirmed by characteristic fluctuation blood glucose that controlled multiple...

10.1177/03000605221121940 article EN Journal of International Medical Research 2022-09-01

Abstract Background There are no reliable molecular targets for early diagnosis and effective treatment in the clinical management of diabetic kidney disease (DKD). To identify novel gene factors underlying progression DKD. Methods The public transcriptomic datasets alloxan-induced DKD model streptozotocin-induced were retrieved to perform an integrative bioinformatic analysis differentially expressed genes (DEGs) shared by two experimental animal models. dominant biological processes...

10.21203/rs.3.rs-2560888/v1 preprint EN cc-by Research Square (Research Square) 2023-03-23
Coming Soon ...